RenovaCare, Inc. (OTCQB: RCAR), developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the first-ever public display of its breakthrough technology, on exhibit now at the UK’s prestigious Science Museum in London.
Featured in the Tomorrow’s World gallery is the latest iteration of the RenovaCare SkinGun™, a futuristic, easy-to-use hand held medical device that delivers a healing mist of stem cells to wounds using an ultra-gentle spray technology.
Today’s SkinGun™ is a significant technological enhancement over its predecessor, that was used successfully to treat a variety of severe burn injuries including gas and chemical explosions, as well as electrical, gasoline, hot water and tar scalding burns.
(Click here to view before-after patient photos)
In as little as 90 minutes a burn patient’s own stem cells are isolated from a sample of healthy skin and sprayed on to wounds for rapid healing. The donor area is tiny, as small as one square inch. The harvested cells are suspended in saline and gently sprayed with RenovaCare’s SkinGun™.
As in the case of State Trooper Matt Uram – one of dozens of burn victims treated to date – patients are able to leave the hospital within only a few days. Current treatments, such as skin grafting, require hospital stays of many weeks while patients undergo painful, costly, and often disfiguring surgeries.
(Click here to watch video of State Trooper’s Stem Cell Recovery)
*RenovaCare products are currently in development. They are not available for sale in the United States. There is no assurance that the company’s planned or filed submissions to the U.S. Food and Drug Administration, if any, will be accepted or cleared by the FDA.
About the Science Museum
As the home of human ingenuity, the Science Museum’s world-class collection forms an enduring record of scientific, technological and medical achievements from across the globe. Welcoming over three million visitors a year, the Museum aims to make sense of the science that shapes our lives, inspiring visitors with iconic objects, award-winning exhibitions and incredible stories of scientific achievement. More information can be found at sciencemuseum.org.uk.
About the RenovaCare
RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs, and novel medical grade liquid sprayer devices.
RenovaCare, Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the body’s largest organ, the skin. The company’s flagship technology, the CellMist™ System, uses its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. RenovaCare is developing its CellMist™ System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars. In the US alone, this $45 billion market is greater than the spending on high-blood pressure management, cholesterol treatments, and back pain therapeutics.